Complain about a product or service

Life Without Vioxx

What's A Patient To Do?

October 1, 2004
The abrupt withdrawal of Vioxx leaves many patients wondering what to do for pain relief. Vioxx was touted as being easy on the stomach, unlike many other pain remedies that can cause gastric distress, ulcers and bleeding.

Related Stories • Pfizer Pays $894 Million to Settle NSAID Claims • Researchers Claim Vioxx Safety Study Was Actually Marketing Plan • First Vioxx Judgment Overturned On Appeal • Merck Agrees to Pay $58 Million to Settle Vioxx Claims • Researchers Claim Merck Cooked Vioxx Data • Common Pain Relievers May Boost Muscle Mass • More Painkillers Can Cause More Pain • Merck Caves, Agrees To $4.85 Billion Vioxx Settlement • New York Sues Vioxx Maker over Drug’s Risks • Merck Wins Vioxx Case In Illinois • Judge Rules Out Vioxx "Super" Class Action • FDA Critic Blasts Merck's Vioxx Replacement • Merck Loses New Orleans Vioxx Case • Merck Wins Latest Vioxx Suit • Vioxx Study Authors Backtrack On Claim • Older Painkillers May Increase Heart Attack Risk • More about Vioxx --- Other NSAIDs • Bextra • Celebrex • Dangers of Other Vioxx-Type Drugs • Vioxx Alternatives • Aleve Ingredient Seen as Health Risk

Merck withdrew the drug after tests found a risk of heart attacks and strokes in patients who had taken it for 18 months.

For many patients, the simplest -- and cheapest -- solution is to go back to over-the-counter drugs like ibuprofen and naproxen, better known as Advil and Aleve. While they may cause digestive distress in some patients, there are medications -- like Pepcid -- that can help reduce the discomfort.

As always, diet and exercise are the cheapest and least potentially harmful ways to reduce the pain of osteoathritis and other maladies aggravated by being sedentary and overweight.

By the way, patients don't have to worry about going off Vioxx suddenly. Unlike many drugs, there is no need to taper off.

Vioxx was one of a class of drugs known as COX-2 inhibitors. Thus, the most obvious alternative for many patients who had good results with Vioxx is to switch to another COX-2 drug, like Pfizer's Celebrex and Bestra.

Like Vioxx, Celebrex and Bextra are easy on the stomach. But do they also present a risk of vascular problems? Some researchers say there's no indication of that. But the European Agency for the Eavluation of Medicinal Products recommends against any COX-2 drug for patients predisposed to cardiovascular ailments.

The truth is there haven't been any rigorous long-term studies yet, so no one can say for sure.

What about those who've been taking Vioxx for a year or two? Most researchers think the risk of heart attack and stroke go away when the drug is discontinued. But, again, there have been no rigorous studies so no one really knows.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Back to the top |

Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.